Nadia Arang

University of California, San Francisco — United States

Medicine · Health Sciences

20h-index1.9kcitations89works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ocular Oncology and Treatments(18), Innovation Policy and R&D(17), Advanced Breast Cancer Therapies(12), Semiconductor materials and devices(11), Hippo pathway signaling and YAP/TAZ(11)

Publications89 total

Unraveling Resistance Mechanisms to Gαq Pathway Inhibition in Uveal Melanoma: Insights from Signaling-Activation Library Screening
Cancers·2025Open Access
Inhibition of anti-apoptotic BCL2 overcomes adaptive resistance to co-targeting of the protein kinase FAK and MEK in GNAQ-driven uveal melanoma
Journal of Biological Chemistry·2025· 1 citedOpen Access
A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system
Proceedings of the National Academy of Sciences·2025Open Access
Supplementary Figure 4 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Supplementary Figure 3 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Supplementary Figure 1 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Supplementary Tables 2 -5 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Supplementary Table 1 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
Supplementary Figure 2 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2025Open Access
FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma
Cancer Cell·2025· 22 cited
Abstract PR008: CD4+ T cell rest and activation is enabled by centralized control of state specific regulatory genes
Cancer Immunology Research·2025
Central control of dynamic gene circuits governs T cell rest and activation
Nature·2024· 21 citedOpen Access
Supplementary Figure 4 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2024Open Access
Supplementary Tables 2 -5 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2024Open Access
Supplementary Figure 3 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2024Open Access
Supplementary Figure 1 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2024Open Access
Supplementary Figure 2 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2024Open Access
Supplementary Table 1 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2024Open Access
Using machine learning to dissect host kinases required for Leishmania internalization and development
Molecular and Biochemical Parasitology·2024· 3 citedOpen Access
Supplementary Table 1 from A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC
2024Open Access
page 1 of 5Next →

Frequent Co-authors

J. Silvio Gutkind(32), Ayush Kishore(19), Kyle Ford(17), Xiaodong Feng(15), Prashant Mali(14), Simone Lubrano(13), Xingyu Wu(13), Toshinori Ando(13), Yusuke Goto(13), Hiroki Izumi(13), Alexis Kaushansky(12), Jonathan A. Pachter(11), Kuniaki Sato(11), Keiichi Koshizuka(11), Michael M. Allevato(11), Tomohiko Ishikawa(10), Zhiyong Wang(10), Sílvia Coma(9), Heather S. Kain(8), Andrew E. Aplin(8)